ArticleThe Analyst2026
Lyophilised colourimetric LAMP for visual readout with dual colour indicators.
Article in The Analyst, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Loop-mediated isothermal amplification (LAMP) is increasingly recognised as a practical alternative to PCR for pathogen detection, offering rapid turnaround time, a constant operating temperature, and compatibility with a wide range of detection methods. Colourimetric LAMP has gained popularity due to its potential for instrument-free readout, making it suitable for molecular diagnostics in low-resource settings. Despite these advantages, its adoption at the point-of-care remains limited as it has been widely used in liquid format and therefore restricted to the availability of cold-chain storage and trained personnel. This work introduces the development and optimisation of ready-to-use lyophilised colourimetric LAMP (lyo-cLAMP) that does not require cold-chain, additional reagents, or manual intervention beyond the addition of extracted nucleic acids from a sample, which indicates the presence of a target of interest by colour change after amplification. A variety of pH and metal indicators were screened and combined to evaluate their synergy, identifying four combinations with high discrimination between positive and negative amplification. The performance of lyo-cLAMP was assessed with synthetic SARS-CoV-2 RNA, comparing it to the liquid format and achieving the same limit-of-detection. Lastly, the translation of lyo-cLAMP to diagnostic applications was demonstrated by screening positive SARS-CoV-2 residual clinical samples, achieving high accuracy. The developed lyo-cLAMP is compatible with any LAMP assay, allowing for rapid adaptation to new targets, which is particularly valuable in outbreak scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.